Christine Pellizzari
2019 - INSMED
In 2019, Christine Pellizzari earned a total compensation of $2.7M as Chief Legal Officer at INSMED, a 33% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $224,200 |
|---|---|
| Option Awards | $1,274,993 |
| Salary | $449,200 |
| Stock Awards | $749,971 |
| Other | $11,200 |
| Total | $2,709,564 |
Pellizzari received $1.3M in option awards, accounting for 47% of the total pay in 2019.
Pellizzari also received $224.2K in non-equity incentive plan, $449.2K in salary, $750K in stock awards and $11.2K in other compensation.
Rankings
In 2019, Christine Pellizzari's compensation ranked 4,501st out of 13,971 executives tracked by ExecPay. In other words, Pellizzari earned more than 67.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,501 out of 13,971 | 68th |
Division Manufacturing | 1,677 out of 5,701 | 71st |
Major group Chemicals And Allied Products | 585 out of 2,200 | 73rd |
Industry group Drugs | 492 out of 1,886 | 74th |
Industry Pharmaceutical Preparations | 372 out of 1,398 | 73rd |
Source: SEC filing on March 31, 2020.
Pellizzari's colleagues
We found six more compensation records of executives who worked with Christine Pellizzari at INSMED in 2019.
2019
William Lewis
INSMED
Chief Executive Officer
2019
Roger Adsett
INSMED
Chief Operating Officer
2019
S Schaeffer
INSMED
Chief People Strategy Officer
2019
Paolo Tombesi
INSMED
Chief Financial Officer
2019
John Goll
INSMED
Former Principal Financial Officer
2019
Martina Flammer
INSMED
Chief Medical Officer
News
Science 37 Holdings CEO David Coman's 2022 pay slips 4% to $8.1M
March 20, 2023
Science 37 Holdings CEO David Coman's 2021 pay jumps 656% to $8.4M
March 23, 2022
INSMED CEO William Lewis' 2020 pay slips 14% to $6.2M
April 1, 2021
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019